CD274 and cancer: The expression of PD-L1 on solid tumors and the key role of the PD-1/PD-L1 and CTLA-4 pathways in tumors, as mechanisms to evade the host’s immune system, represent the biological rationale for their use as potential targets in cancer treatment.